Abstract |
To identify novel, tumor-specific target antigens for vaccine development, we studied immune responses to P.polypeptide, an M(r) 110,000 integral melanosomal membrane protein associated with the Prader-Willi syndrome. Together with expressed sequence tag (EST) and serial analyses of gene expression (SAGE) library analyses, reverse transcription-PCR and Northern blotting verified that P.polypeptide expression was limited to melanoma and melanocytes. A single dominant epitope corresponding to positions 427-435 (IMLCLIAAV) was identified using allele-specific epitope forecasting combined with work in HLA-A*0201/K(b) transgenic mice. This epitope was then used to generate de novo human P.polypeptide-specific CD8+ T cells capable of recognizing P.polypeptide expressing human tumor cell lines in an HLA-A*0201-restricted fashion. Thus, P.polypeptide may be valuable in the creation of novel therapeutic anticancer vaccines.
|
Authors | C E Touloukian, W W Leitner, P F Robbins, S A Rosenberg, N P Restifo |
Journal | Cancer research
(Cancer Res)
Vol. 61
Issue 22
Pg. 8100-4
(Nov 15 2001)
ISSN: 0008-5472 [Print] United States |
PMID | 11719435
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antigens, Neoplasm
- Cancer Vaccines
- Epitopes
- Epitopes, T-Lymphocyte
- H-2 Antigens
- H-2Kb protein, mouse
- HLA-A Antigens
- HLA-A*02:01 antigen
- HLA-A2 Antigen
- P.polypeptide
- Peptides
- RNA, Messenger
|
Topics |
- Animals
- Antigen Presentation
- Antigens, Neoplasm
(biosynthesis, genetics, immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cancer Vaccines
(immunology)
- Epitopes
(immunology)
- Epitopes, T-Lymphocyte
(immunology)
- H-2 Antigens
(immunology)
- HLA-A Antigens
(immunology)
- HLA-A2 Antigen
- Humans
- Melanoma
(genetics, immunology, metabolism)
- Melanosomes
(immunology, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Peptides
(genetics, immunology)
- RNA, Messenger
(biosynthesis, genetics)
|